Lisbon buying Heroin

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Lisbon buying Heroin

These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format. All countries. Topics A-Z. The content in this section is aimed at anyone involved in planning, implementing or making decisions about health and social responses. Best practice. We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon. Explore our wide range of publications, videos and infographics on the drugs problem and how Europe is responding to it. All publications. More events. More news. We are your source of drug-related expertise in Europe. We prepare and share independent, scientifically validated knowledge, alerts and recommendations. About the EUDA. Following an external evaluation of the EMCDDA, the European Commission called for a broader and more proactive remit for the agency in January to help it address new challenges posed by an increasingly complex drug phenomenon. New mechanisms have been created to help achieve this goal. These include a European Drug Alert System, to issue alerts when serious drug-related risks appear on the market, and a European Threat Assessment System to boost how the EU prepares for, and reacts to, emerging or potential health and security threats. The agency will be supported by a network of EUDA national focal points and a European Network of Toxicology and Forensic Laboratories, designed to foster information exchange on new trends and to train national toxicologists and forensic drug experts. The new agency has been given a stronger role in the area of international cooperation. The agreement is designed to enhance cooperation in addressing drug-related challenges. This closed event will bring together for the first time the formally nominated Board members to take key institutional decisions linked to the new EUDA regulation. The Board will adopt its rules of procedure and elect members to the Executive Board and Budget Committee. It will also appoint members to the EUDA Scientific Committee and approve a list of experts for risk assessments of new psychoactive substances. A list of EUDA national focal points and their heads and of national representative laboratories appointed to the EUDA network of forensic and toxicological laboratories will also be presented to the Board. On 5 July, the meeting will be extended to include high-level representatives from candidate countries and potential candidates to the EU, as well as non-EU countries with which the EUDA collaborates. Executive Directors of other EU agencies will also attend. Geostrategic discussions will focus on international cooperation and emerging drug trends. This represents a new impulse in our commitment to address the drug situation comprehensively and to step up efforts to fight drug trafficking and organised crime'. I am convinced that, with its fit-for-purpose mission, the EUDA will provide significant added value to policymakers and professionals as they address the causes and consequences of drug use'. As the EUDA, we have a broader mandate to anticipate future drug-related challenges and to alert in real time on new drug risks and threats. We will also help the EU and Member States strengthen their responses and we will facilitate EU-wide knowledge exchange and learning for evidence-based drug policies and interventions. We are at a pivotal moment in the history of EU action in the field of illicit drugs and are on a clear course towards boosting EU preparedness in this complex field. I would also like to express my gratitude to my staff for their commitment and dedication. They have made extraordinary efforts to create the new agency while continuing to deliver on our current mandate'. The European Parliament and the Council of the EU examined and adopted the new mandate, according to the EU ordinary legislative procedure. Commission proposes stronger mandate for EU Drugs Agency as illicit market proliferates 12 January Council gives final green light to creation of EU drugs agency 27 June To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:. Kathy Robertson Principal manager Media relations and corporate communication. Email: Kathy Robertson. Homepage Quick links Quick links. GO Results hosted on duckduckgo. Main navigation Data Open related submenu Data. Latest data Prevalence of drug use Drug-induced deaths Infectious diseases Problem drug use Treatment demand Seizures of drugs Price, purity and potency. Drug use and prison Drug law offences Health and social responses Drug checking Hospital emergencies data Syringe residues data Wastewater analysis Data catalogue. Selected topics Alternatives to coercive sanctions Cannabis Cannabis policy Cocaine Darknet markets Drug checking Drug consumption facilities Drug markets Drug-related deaths Drug-related infectious diseases. Recently published Findings from a scoping literature…. Penalties at a glance. Frequently asked questions FAQ : drug…. FAQ: therapeutic use of psychedelic…. Viral hepatitis elimination barometer…. EU Drug Market: New psychoactive…. EU Drug Market: Drivers and facilitators. Statistical Bulletin home. Quick links Search news Subscribe newsletter for recent news Subscribe to news releases. Location Lisbon. Publication date. The agency's work will be organised around four inter-connected service categories: Anticipate: Helping the EU and its Member States anticipate future drug-related challenges and their consequences. Alert: Issuing real-time alerts on new drug risks and threats to health and security. Learn: Facilitating EU-wide knowledge exchange and learning for evidence-based drug policies and interventions. Working Arrangement with Ecuador The new agency has been given a stronger role in the area of international cooperation. Target audience. Previous slide. Next slide. Frequently asked questions FAQ : drug overdose deaths in Europe. FAQ: therapeutic use of psychedelic substances. Viral hepatitis elimination barometer among people who inject drugs. Wastewater analysis and drugs — explore the latest data. Cannabis laws in Europe: questions and answers for policymaking.

Changes and trends in how people are buying drugs

Lisbon buying Heroin

Connolly, Johnny Reports examine effects of decriminalisation of drugs in Portugal. Drugnet Ireland, Issue 30, Summer , pp. Portugal became the first country in the European Union to decriminalise all drugs, including cocaine and heroin, under a statue passed in Drug trafficking continues to be prosecuted as a criminal offence. The law, according to a report commissioned by the Beckley Foundation,2 'formed part of a strategic approach to drug use which aimed to focus police resources on those people who profit from the drugs trade, while enabling a public health approach to drug users' p. A recent analysis of the legal reforms by the US-based Cato Institute3 has concluded that 'judged by virtually every metric, the Portuguese decriminalization framework has been a resounding success' p. Repository Staff Only: item control page. Skip to main content Link to Health Research Board twitter page, opens in new window Link to Health Research Board r s s feed, opens in new window drugslibrary hrb. Preview Title Contact Preview. Although several EU states have developed either formal or de facto forms of de-penalisation, particularly for personal cannabis use, whereby offenders seldom receive custodial sanctions, no EU state except Portugal has explicitly decriminalised drugs. Under the statute, decriminalisation applies to the consumption, purchase and possession of all drugs for 'one's own consumption', which is defined as a quantity 'not exceeding the quantity required for an average individual consumption during a period of ten days' Article 2. No distinction is made between drug types or between public and private consumption. The statute establishes Commissions for the Dissuasion of Drug Addiction CDTs to adjudicate and impose appropriate sanctions for violations of the new law. The CDTs comprise three members appointed jointly by the ministries of justice and health and the government's co-ordinator of drug policy, whereby one will have legal training and at least one of the other two will have a medical or social services background. In the absence of evidence of addiction or repeated violations, the imposition of a fine is to be suspended. The CDT can also suspend sanctions on condition that the offender attends treatment. The Cato report points out that it is difficult to enforce such conditions in practice 'since violations of a commission's rulings are not, themselves, infractions of any law' p. Where offenders are deemed to be addicted to drugs, the CDT can impose a range of other sanctions, including, as summarised in the Cato report, 'suspension of the right to practise a licensed profession doctor, lawyer, taxi driver ; a ban on visiting high-risk locales nightclubs ; a ban on associating with specified individuals; In determining the appropriate sanction, the CDT must consider factors such as 'the seriousness of the act; the type of drug consumed; whether consumption was public or private; and whether usage is occasional or habitual' p. However, providing drugs to a minor or to a person with mental illness is considered an aggravating factor under the general prohibition of trafficking, which is punishable by imprisonment of between four and 12 years. Police officers who observe drug use or possession are required to issue citations to the offender, but they are not permitted to make an arrest. The citation is sent to the CDT and the administrative process then commences. The Cato report notes that the reaction of police officers to the initiative has been mixed, with some believing that 'the issuance of citations, without arrest or the threat of criminal prosecutions, is worthless' p. The Beckley Foundation report described the nature of the support for the latter view:. The law enforcement sector was seen as supportive of the reform, particularly because they perceived decriminalization and referral to education and treatment as offering a better response to drug users than under the previous legislative approach. Key informants asserted law enforcement have embraced the more preventative role for drug users. Cannabis continues to be the substance for which the greatest percentage of drug offenders are cited. Despite fears expressed by those opposing the reform prior to , decriminalisation has not led to an increase in drug use. On the contrary, lifetime drug prevalence rates have decreased in Portugal since the reform. For the critical age groups of years and years, 'prevalence rates have declined for virtually every substance since decriminalization' p. Furthermore, the author links a fall in the numbers of new cases of drug-related HIV and AIDS, hepatitis B and C infection, and drug-related death to the coming into effect of the law in Although he acknowledges that these trends started prior to and were due in part to education reforms and harm reduction initiatives introduced in Portugal, he suggests that the removal of the fear and stigma of arrest and prosecution incentivised drug users to avail of these new treatment and education initiatives. The analysis by the Beckley Foundation sounds a more cautious note, which probably accurately reflects the current debate about decriminalisation in Portugal:. Decriminalization has enabled earlier intervention and more targeted and therapeutic responses to drug users, increased collaboration across a network of services and increased attention to adopting policies that work. Yet, key informants also highlighted that impacts were less than expected and that there were concerns over the message that decriminalization was sending to new drug users. Briefing paper Oxford: The Beckley Foundation. Available at www. Greenwald G Drug decriminalization in Portugal: lessons for creating fair and successful drug policies. Washington DC: Cato Institute. Item Type. Publication Type. International, Open Access, Article. Drug Type. Issue Title. Issue 30, Summer Page Range. Health Research Board. Accession Number. HRB Available.

Lisbon buying Heroin